Jones Financial Companies’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Sell
8,693
-9,161
-51% -$1.9M ﹤0.01% 1636
2026
Q1
$3.94M Buy
17,854
+13,396
+300% +$3.34M ﹤0.01% 1167
2025
Q4
$1.07M Buy
4,458
+1,545
+53% +$395K ﹤0.01% 1201
2025
Q3
$788K Buy
2,913
+74
+3% +$20.2K ﹤0.01% 1219
2025
Q2
$725K Buy
2,839
+706
+33% +$168K ﹤0.01% 1130
2025
Q1
$470K Buy
2,133
+245
+13% +$57.2K ﹤0.01% 1153
2024
Q4
$432K Buy
1,888
+523
+38% +$126K ﹤0.01% 1047
2024
Q3
$327K Buy
1,365
+455
+50% +$102K ﹤0.01% 975
2024
Q2
$174K Buy
910
+833
+1,082% +$169K ﹤0.01% 877
2024
Q1
$15.2K Buy
77
+66
+600% +$12.1K ﹤0.01% 967
2023
Q4
$1.89K Buy
+11
New +$1.69K ﹤0.01% 918
2023
Q1
Sell
-7
Closed -$1K 747
2022
Q4
$1K Hold
7
﹤0.01% 702
2022
Q3
$2K Sell
7
-14
-67% -$3.19K ﹤0.01% 512
2022
Q2
$4K Hold
21
﹤0.01% 562
2022
Q1
$5K Sell
21
-7
-25% -$1.69K ﹤0.01% 586
2021
Q4
$7K Buy
+28
New +$7.27K ﹤0.01% 604
2021
Q2
Sell
-20
Closed -$4K 767
2021
Q1
$4K Sell
20
-12
-38% -$2.41K ﹤0.01% 671
2020
Q4
$7K Buy
+32
New +$6.38K ﹤0.01% 468

Other funds holding RMD

Jones Financial Companies's RMD Position: Q2 2026 in Review

Jones Financial Companies reduced its ResMed (RMD) stake by 51% in Q2 2026, selling an estimated $1.9M and leaving 8,693 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #1636.

Jones Financial Companies first reported a position in RMD in Q4 2020 and has held it in 18 quarters since. The position peaked at $3.94M in Q1 2026. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Jones Financial Companies held 8,693 shares of ResMed worth $1.74M as of Q2 2026.
  • Jones Financial Companies sold 9,161 ResMed shares in Q2 2026, an estimated $1.9M.
  • ResMed made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1636 holding.
  • Jones Financial Companies first reported a position in ResMed in Q4 2020 and has held it in 18 quarters since.
  • Jones Financial Companies's ResMed position peaked at $3.94M in Q1 2026.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.